. city, Kanagawa 221, Japan
The in-vitro fertilization (IVF) and embryo transfer procedure has become a common assisted reproductive technique. A 3 To whom correspondence should be addressed serious complication of this procedure is ovarian hyperstimulaChanges in CA602 and CA546, two carbohydrate-related tion syndrome (OHSS), which is caused by the over-induction antigens newly established in our institute, were evaluated of ovulation by pharmacological means (Bettendorf and during the course of in-vitro fertilization and embryo Lindner, 1987) . Though the mechanism of OHSS is not transfer. The concentration of CA602, an antigen with clarified, the support of luteal function with injections of characteristics similar to those of CA125, did not change human chorionic gonadotrophin (HCG) is known to be one of substantially until embryo transfer. In patients with clinical the causes of OHSS. The discovery of indicators that could evidence of ovarian hyperstimulation syndrome (OHSS), a reveal the onset and the degree of severity of this syndrome significant increase in serum concentrations of CA602 was would be therefore of the utmost clinical importance. A few observed 10 days after embryo transfer (P < 0.01). There attempts have been made to evaluate the usefulness of tumour were no significant changes in the patients without OHSS.
markers in the diagnosis of OHSS, but only some studies have A significant elevation of oestradiol concentration in OHSS followed the changes in tumour markers from the beginning patients was also observed, with the variation before oocyte of ovarian stimulation (Jaeger et al., 1987 ; Eisermann and retrieval being greater than that seen with CA602. The Collins, 1989; Lanzone et al., 1990; Zweers et al., 1990 ). concentration of CA546, which had lower false-positive Accordingly, in this study we measured the changes in serum rates in benign disease, did not differ significantly in the concentrations of CA602 during IVF and embryo transfer to OHSS and non-OHSS patients. Our data demonstrate that evaluate its use as a marker for the diagnosis of OHSS. Serum serum concentrations of CA602 are increased even in early concentrations of CA546 were also monitored. stages of OHSS, and suggest a possible role for this antigen as a marker for OHSS.
Introduction
bilateral tubal occlusion, in the outpatient clinic of Saiseikai KanagaTumour markers are potentially useful in the diagnosis of waken Hospital (Yokohama-city, Kanagawa, Japan). All patients desired the IVF and embryo transfer procedure. Five of the 17 patients malignant diseases. Recently we established two new tumour were excluded because of endometriosis. Finally, 12 patients aged markers for ovarian cancers, CA602 (Nozawa et al., 1991) 26-40 years were registered. and CA546 (Nozawa et al., 1989) . CA602, a protein antigen, A hormonal examination, including a gonadotrophin-releasing showed high positive rates in patients with ovarian cancer, hormone (GnRH) and a thyrotrophin-releasing hormone test, before especially in those with serous cystadenocarcinoma. This the IVF and embryo transfer procedure showed no abnormal hormonal marker exhibits characteristics similar to those of CA125 (Bast conditions. et al., 1983) and shows a relatively high false-positive rate in the presence of endometriosis (Suzuki et al., 1990 ; Nozawa IVF and embryo transfer procedure et al., 1991) . CA546, a glycosidic chain antigen, shows high
The IVF and embryo transfer procedure was performed as described positive rates in patients with mucinous cystadenocarcinoma previously (Konishi et al., 1993) . Individualized ovarian stimulation and low false-positive rates in patients with benign diseases was performed with pure follicle stimulating hormone (FSH)-human including endometriotic cysts (Nozawa et al., 1992a) . Thus, menopausal gonadotrophin (HMG)-HCG in combination with GnRH these two markers have complementary potential for estabanalogue. Briefly, while endogenous gonadotrophins were being suppressed with GnRH analogue (Suprecure; Hoechst, Frankfurt, lishing the diagnosis of ovarian cancer (Nozawa et al., 1992b) . interassay coefficients of variation were Ͻ4.4-6.0% for CA602 and oocyte retrieval. n ϭ number of patients; OHSS ϭ ovarian Ͻ2.5-7.5% for CA546. hyperstimulation syndrome.
The serum concentration of oestradiol was measured with semiautomatic equipment (SR-1; Biochem Immunosystems, Tokyo, Japan). The complete blood count and total protein concentration in serum Germany), pure FSH (Fertinom P; Serono Japan, Tokyo, Japan) was were also measured. administered for 4 days following the administration of HMG To detect OHSS after embryo transfer, patients were checked using (Humegon; Sankyo, Tokyo, Japan). When the diameter of the leading transvaginal ultrasonography and questioned about their condition. follicle was Ͼ17 mm, 10 000 IU HCG (HCG Mochida; Mochida, According to the classification of OHSS by the World Health Tokyo, Japan) were injected. Oocytes were retrieved transvaginally Organization (WHO Scientific Group, 1973) , patients with swelling under ultrasonographic guidance 36 h after the injection. After 48 h, of the ovaries to Ͼ5 cm in diameter were categorized as having fertilized eggs were transferred to the uterine cavity. After the embryo OHSS. Massive ascites and complaints of lower abdominal pain were transfer, HCG was injected every 2 days on five occasions to support also defined as OHSS. the luteal phase. A pregnancy test was performed on day 14 after oocyte retrieval.
Statistical analysis Blood samples were collected as follows: (i) during the previous Data are presented as the means Ϯ SEM. A statistical analysis was cycle (not in the menstrual period) for the purposes of excluding performed using paired or non-paired Student's t-tests. The post-hoc women with apparent endometriosis; (ii) when the leading follicle test was Scheffé's F-test. Differences were considered to be statisticgrew to Ͼ15 mm in diameter; (iii) at oocyte retrieval; (iv) at embryo ally significant if the P value was Ͻ0.05. All analyses were performed transfer; and (v) 10 days after embryo transfer.
using standard computer software for statistical analysis (StatViewAssays for tumour markers and hormones J, version 4.02; Abacus Concept Inc., Berkeley, CA, USA). Serum concentrations of CA602 and CA546 were measured with kits from Mochida Co. Ltd, which were based on the double-determinant Results enzyme immunoassay (Nozawa et al., 1992b,c) . The threshold values Of the 12 women who underwent pharmacological induction for distinguishing women with ovarian cancer from healthy women were set at 63 U/ml for CA602 and 12 U/ml for CA546. The of ovulation, five (41.6%) developed OHSS. All had mild or the OHSS group, the serum concentrations of CA602 were significantly increased 10 days after embryo transfer. At this point, the mean serum concentration of CA602 in the OHSS group was significantly higher than that in the non-OHSS group (Table I) . The CA546 concentration did not change substantially during the course of IVF and embryo transfer (Figure 2) . No difference in the CA546 concentration was found between the OHSS and the non-OHSS groups.
The concentrations of oestradiol before oocyte retrieval were 1358.4 Ϯ 395.4 pg/ml in the OHSS group and 556.7 Ϯ 111.3 pg/ml in the non-OHSS group; the difference was not statistically significant. However, 10 days after embryo transfer, the concentration of oestradiol in the OHSS group (3951.5 Ϯ 706.0 pg/ml) was significantly higher than that in the non-OHSS group (773.5 Ϯ 169.8 pg/ml) (Figure 3 ).
Discussion
CA602 and CA546 are newly established carbohydrate-related tumour markers in our institute, which are used for the diagnosis of ovarian cancers. To evaluate the possibility of tumour markers also acting as markers for OHSS, we measured the serum concentrations of CA602 and CA546 at five points during IVF and embryo transfer. Although no change in the CA602 concentration was observed until embryo transfer in the OHSS group, there was an immediate and sharp increase 10 days after embryo transfer. At the time of oocyte retrieval, a needle is inserted into the ovary; the bleeding that occurs could lead to stimulation of the peritoneum. However, in the non-OHSS group, there was no change in the course of the reported that CA602 and CA125 concentrations do increase in the first trimester of pregnancy (Halila et al., 1986; Nozawa et al., 1991) . However, there were two patients in the OHSS moderate stage OHSS, and no severe haemoconcentration was observed. There was no significant difference in complete group who were not pregnant but who showed an increase in CA602, and one pregnant patient without OHSS but with no blood count or total protein concentration during the course of the study in both the OHSS and non-OHSS groups. The increase in CA602. These results suggested that the elevation of CA602 in the OHSS group could indeed be explained number of follicles observed before oocyte retrieval was 8.0 Ϯ 1.3 in the OHSS group and 3.9 Ϯ 0.3 in the non-OHSS by OHSS. All cases of OHSS in this study were never more than at group, and this was a significant difference (P Ͻ 0.01). The numbers of oocytes retrieved and fertilized were 7.4 Ϯ 1.0 the grade II or moderate stage (Rabau et al., 1967; Schenker and Weinstein, 1978; Bettendorf and Lindner, 1987 ; Blankstein and 5.4 Ϯ 1.4 respectively in the OHSS group, and 3.1 Ϯ 0.7 and 1.7 Ϯ 0.3 respectively in the non-OHSS group. Both et al., 1987) . Even at this early stage, the serum concentrations of CA602 were increased significantly compared with those differences were statistically significant (P Ͻ 0.01 and P ϭ 0.01 respectively). At most, three fertilized oocytes were in the non-OHSS group. In contrast, CA546 showed no significant change, confirming the low rate of false-positives transferred. Four pregnancies occurred in the study subjects. The course of the three pregnancies in the OHSS group was for this marker. During the time-course of the experiment, changes in the uneventful. The one pregnancy in the non-OHSS group ended in a chemical abortion.
concentration of CA602 were not large enough to detect OHSS in its early stages, such as before embryo transfer. With The mean concentrations of CA602 in the OHSS group were higher than those in the non-OHSS group at all sampling reference to CA125, the concentration of this antigen has been reported to increase in patients with OHSS (Jaeger et al., points through to embryo transfer, but at no time was there a statistically significant difference. During stimulation of the 1987). Scarpellini and Scarpellini (1992) also found that CA125 was increased 8 days after ovulation. The elevation of ovaries and until embryo transfer, the CA602 concentrations in both the OHSS and the non-OHSS groups were steady, CA125 was detected in the mid-luteal phase (Oezaksit et al., 1993) . From these data, it seems that tumour markers may not almost below the threshold value of 63 U/ml (Figure 1) . In be suitable predictors of OHSS, but may be indicators of concentrations of CA602. There was a case in our study, for example, in which the oestradiol concentration was high, OHSS. Compared with CA125, the great advantage of CA602 is higher sensitivity. The detection limits of both markers were~2800 pg/ml, before oocyte retrieval, but the CA602 concentration was in the normal range, 52 U/ml. In the patients excluded almost the same since it was known that 258 CA602 units were equal to 108 CA125 units (Nozawa et al., 1991) . The from this study because of endometriosis, high oestradiol concentrations before oocyte retrieval were not related to gradient of the standard curve (units-absorbance curve) for the CA602 kit is steeper than that for the CA125 kit. Thus, CA602 concentrations (data not shown).
From the economic point of view, the analysis of tumour CA602 can detect a smaller change with an at least 2-fold greater sensitivity than CA125. Recently, a second-generation markers is a relatively high cost procedure. However, this is balanced by high sensitivity, and much progress has been CA125 assay was introduced into clinical use. However, it was reported that the ability of this assay to differentiate made towards establishing simpler and cheaper kits for measuring CA602. between patients with and without endometriosis is small, especially in the lower range (Hornstein et al., 1995) . From
In conclusion, our preliminary results suggest that CA602 may serve as an indicator of OHSS. Further prospective these points of view, CA602 is especially useful when small changes in a narrow range are considered, as in OHSS.
investigations of large numbers of patients will reveal its usefulness. The origin of CA602 in OHSS remains to be clarified. One hypothesis is that the gonadotrophic stimulus leads to ovarian enlargement, which modifies the surface of the ovary and also
